SCHEMBL20109336

SCHEMBL20109336

C=C=C(Cc1ccc(Br)cc1)C(=O)OCC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
S1PR4 O95977 1/20 0.49
LMNA P02545 1/20 0.49
S1PR1 P21453 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
CES2 O00748 1/20 0.45
ACHE P22303 1/20 0.45
CES1 P23141 1/20 0.45
KYAT1 Q16773 1/20 0.41
MME P08473 1/20 0.41
ACE P12821 1/20 0.41
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SRD5A2 P31213 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20109359 0.89 KMT2A (0.47) MEN1KMT2AMAPTCES2ACHE
SCHEMBL20109333 0.87 ALDH1A1 (0.49) MEN1KMT2AMAPTMAPK1CES2
SCHEMBL20109356 0.86 MAPT (0.47) MAPTLMNAKYAT1L3MBTL1ALDH1A1
SCHEMBL20109358 0.86 KMT2A (0.48) MEN1KMT2AMAPTLMNANPSR1
SCHEMBL10047306 0.82 MEN1 (0.45) MEN1KMT2AMAPTLMNAL3MBTL1
SCHEMBL20109355 0.81 LMNA (0.50) MEN1KMT2AMAPTLMNAALDH1A1
SCHEMBL6925456 0.81 KMT2A (0.51) MEN1KMT2AMAPTMAPK1S1PR4
SCHEMBL7636374 0.80 KMT2A (0.54) MEN1KMT2AMAPTMAPK1S1PR4
SCHEMBL15964601 0.78 KMT2A (0.49) MEN1KMT2AMAPTMAPK1S1PR4
SCHEMBL4733 0.76 CYP1A2 (0.55) MEN1KMT2AMAPTMAPK1S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MEN1 469/4885KMT2A 2508/4885MAPT 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.